Effects of intranasal dexmedetomidine on postoperative sleep quality: a systematic review and meta-analysis of randomized controlled trials
Frontiers in Medicine · 10.07.2026 · 13
DOI: 10.3389/fmed.2026.1890318 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Medicine, online erschienen am 10.07.2026. Verfasst von Jiacheng Zhao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Suzhou Ninth Hospital Affiliated to Soochow University, Suzhou, China. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Schlaf
Abstract (Originalsprache)
Background
Postoperative sleep disturbance is common in surgical patients and may slow recovery. Dexmedetomidine has a sleep like sedative effect, and intranasal administration provides a convenient and non-invasive route. The aim of our study was to evaluate the effect of intranasal dexmedetomidine on postoperative sleep quality in adult surgical patients.
Methods
We performed a systematic review and meta-analysis of randomized controlled trials. PubMed, the Cochrane Library and Embase were searched to May 20, 2026. Intranasal dexmedetomidine was compared with placebo or other controls. Subjective and objective sleep outcomes, sleep disturbance and adverse events were analysed using standard meta-analytic methods. Subgroup analyses were further performed according to the route, timing, and duration of administration, as well as patient characteristics, surgical type, anesthesia type, and evaluation scales.
Results
15 trials were included. For subjective scores where a lower value means better sleep, intranasal dexmedetomidine improved postoperative sleep compared with controls (SMD = −1.29, 95% CI [−1.80, −0.77], I 2 = 90%, p < 0.00001). Subgroup analyses suggested that the timing of administration, sex distribution, and surgical type might be important sources of heterogeneity. For scores where a higher value means better sleep, postoperative scores were also higher in the dexmedetomidine group (SMD = 1.75, 95% CI [0.94, 2.57], I 2 = 94%, p < 0.0001). Sleep efficiency (SMD = 1.71, 95% CI [0.94, 2.48], I 2 = 93%, p < 0.0001) and total sleep time (SMD = 1.76, 95% CI [0.67, 2.84], I 2 = 91%, p = 0.002) increased, sleep latency (SMD = −1.07, 95% CI [−1.66, −0.49], I 2 = 86%, p = 0.0003) reduced, while REM sleep, N1 sleep, and N3 sleep did not change. The risk of sleep disturbance decreased (RR = 0.53, 95% CI [0.39, 0.73], I 2 = 74%, p < 0.0001). Adverse events such as delirium, nausea and vomiting, and anxiety were less common in the dexmedetomidine group.
Conclusion
Intranasal dexmedetomidine may improve short-term postoperative sleep, but evidence is limited and more high-quality trials are needed.
Systematic review registration
PROSPERO 2025 CRD420251186146, Available from https://www.crd.york.ac.uk/PROSPERO/view/CRD420251186146 .
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anesthesiology, Suzhou Ninth Hospital Affiliated to Soochow University, Suzhou, China.
- Department of Anesthesiology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Zitieren
APA
Zhao, J., Zhang, C., Li, H., Qiu, Y., Li, J., Cao, H., Zhou, X., Guan, S., Wang, J., & Yao, M. (2026). Effects of intranasal dexmedetomidine on postoperative sleep quality: a systematic review and meta-analysis of randomized controlled trials. Frontiers in Medicine, 13. https://doi.org/10.3389/fmed.2026.1890318
Vancouver
Zhao J, Zhang C, Li H, Qiu Y, Li J, Cao H, et al. Effects of intranasal dexmedetomidine on postoperative sleep quality: a systematic review and meta-analysis of randomized controlled trials. Frontiers in Medicine. 2026;13. doi:10.3389/fmed.2026.1890318
BibTeX
@article{Zhao2026,
author = {Zhao, Jiacheng and Zhang, Chao and Li, Hui and Qiu, Yuxin and Li, Jinbiao and Cao, Hui and Zhou, Xinggen and Guan, Siyao and Wang, Jie and Yao, Ming},
title = {Effects of intranasal dexmedetomidine on postoperative sleep quality: a systematic review and meta-analysis of randomized controlled trials},
journal = {Frontiers in Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fmed.2026.1890318}
}
EUVIMED